NCT01302028View on ClinicalTrials.gov

Renal Impairment Study With ASP1941

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 22, 2010

Primary Completion Date

June 26, 2010

Study Completion Date

June 26, 2010

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

ASP1941

Oral

Trial Locations (5)

8230

Balatonfüred

16900

Prague

62500

Brno

83305

Bratislava

02-097

Warsaw

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY